BE878804A - Vaccin combine contre la maladie de newcastle et le chute de ponte provoquee par des virus adeno-like - Google Patents
Vaccin combine contre la maladie de newcastle et le chute de ponte provoquee par des virus adeno-like Download PDFInfo
- Publication number
- BE878804A BE878804A BE0/197163A BE197163A BE878804A BE 878804 A BE878804 A BE 878804A BE 0/197163 A BE0/197163 A BE 0/197163A BE 197163 A BE197163 A BE 197163A BE 878804 A BE878804 A BE 878804A
- Authority
- BE
- Belgium
- Prior art keywords
- emi
- virus
- adeno
- liquid containing
- newcastle disease
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title claims description 87
- 208000010359 Newcastle Disease Diseases 0.000 title claims description 14
- 229960005486 vaccine Drugs 0.000 title description 42
- 239000007788 liquid Substances 0.000 claims description 44
- 239000000725 suspension Substances 0.000 claims description 21
- 241000711404 Avian avulavirus 1 Species 0.000 claims description 20
- 235000013601 eggs Nutrition 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 241000272525 Anas platyrhynchos Species 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 12
- 239000012071 phase Substances 0.000 claims description 11
- 241000287828 Gallus gallus Species 0.000 claims description 10
- 230000035931 haemagglutination Effects 0.000 claims description 10
- 208000015181 infectious disease Diseases 0.000 claims description 10
- 239000008346 aqueous phase Substances 0.000 claims description 9
- 239000000470 constituent Substances 0.000 claims description 9
- 210000004027 cell Anatomy 0.000 claims description 8
- 238000004113 cell culture Methods 0.000 claims description 7
- 210000002950 fibroblast Anatomy 0.000 claims description 7
- 210000001161 mammalian embryo Anatomy 0.000 claims description 7
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 6
- 230000033001 locomotion Effects 0.000 claims description 6
- 238000005096 rolling process Methods 0.000 claims description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 claims description 6
- 230000000694 effects Effects 0.000 claims description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 claims description 4
- 230000000120 cytopathologic effect Effects 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 230000002458 infectious effect Effects 0.000 claims description 4
- 229960000380 propiolactone Drugs 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 3
- 238000012423 maintenance Methods 0.000 claims description 3
- 239000002736 nonionic surfactant Substances 0.000 claims description 3
- 229940056360 penicillin g Drugs 0.000 claims description 3
- 229960005322 streptomycin Drugs 0.000 claims description 3
- 229910019142 PO4 Inorganic materials 0.000 claims description 2
- 239000000654 additive Substances 0.000 claims description 2
- 210000004381 amniotic fluid Anatomy 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 229960003255 natamycin Drugs 0.000 claims description 2
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 claims description 2
- 239000004311 natamycin Substances 0.000 claims description 2
- 235000010298 natamycin Nutrition 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 2
- 239000010452 phosphate Substances 0.000 claims description 2
- 239000002356 single layer Substances 0.000 claims description 2
- 229940031551 inactivated vaccine Drugs 0.000 claims 6
- 239000002480 mineral oil Substances 0.000 claims 3
- 150000001298 alcohols Chemical class 0.000 claims 2
- 125000002947 alkylene group Chemical group 0.000 claims 2
- 239000001963 growth medium Substances 0.000 claims 2
- 230000000937 inactivator Effects 0.000 claims 2
- 239000002609 medium Substances 0.000 claims 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims 2
- 239000008158 vegetable oil Substances 0.000 claims 2
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 238000004264 monolayer culture Methods 0.000 claims 1
- 239000003755 preservative agent Substances 0.000 claims 1
- 230000002335 preservative effect Effects 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 235000013330 chicken meat Nutrition 0.000 description 9
- 239000000839 emulsion Substances 0.000 description 9
- 244000144977 poultry Species 0.000 description 8
- 235000013594 poultry meat Nutrition 0.000 description 8
- 241000271566 Aves Species 0.000 description 5
- 230000002779 inactivation Effects 0.000 description 5
- 230000005764 inhibitory process Effects 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000002966 serum Anatomy 0.000 description 5
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 244000309466 calf Species 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000000265 homogenisation Methods 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 210000005229 liver cell Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 238000002255 vaccination Methods 0.000 description 3
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 239000012984 antibiotic solution Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 230000000241 respiratory effect Effects 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 241000701161 unidentified adenovirus Species 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical class [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000606790 Haemophilus Species 0.000 description 1
- 241000238367 Mya arenaria Species 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 239000008366 buffered solution Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000003067 hemagglutinative effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000012678 infectious agent Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003292 kidney cell Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000007482 viral spreading Effects 0.000 description 1
- 210000000605 viral structure Anatomy 0.000 description 1
- 229960004854 viral vaccine Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/17—Newcastle disease virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/235—Adenoviridae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10111—Atadenovirus, e.g. ovine adenovirus D
- C12N2710/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL7809364 | 1978-09-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE878804A true BE878804A (fr) | 1980-03-14 |
Family
ID=19831538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE0/197163A BE878804A (fr) | 1978-09-14 | 1979-09-14 | Vaccin combine contre la maladie de newcastle et le chute de ponte provoquee par des virus adeno-like |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPS5547625A (enrdf_load_stackoverflow) |
| BE (1) | BE878804A (enrdf_load_stackoverflow) |
| ZA (1) | ZA794760B (enrdf_load_stackoverflow) |
-
1979
- 1979-09-07 ZA ZA00794760A patent/ZA794760B/xx unknown
- 1979-09-14 JP JP11869279A patent/JPS5547625A/ja active Granted
- 1979-09-14 BE BE0/197163A patent/BE878804A/fr not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6220964B2 (enrdf_load_stackoverflow) | 1987-05-11 |
| ZA794760B (en) | 1980-08-27 |
| JPS5547625A (en) | 1980-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1232249B1 (fr) | Pneumovirus du canard et vaccins correspondants | |
| EP0073547B1 (en) | Infectious-bronchitis vaccines for poultry, combined infectious-bronchitis vaccines, process for preparing such vaccines and infectious-bronchitis virus strain | |
| Lambrechts et al. | Challenge experiments to evaluate cross‐protection induced at the trachea and kidney level by vaccine strains and Belgian nephropathogenic isolates of avian infectious bronchitis virus | |
| CA1277270C (fr) | Procede de culture du virus de la rhinotracheite infectieuse, notamment de la dinde, et vaccin prepare a partir du virus ainsi obtenu | |
| US4505892A (en) | Infectious bronchitis vaccine for poultry | |
| JP2000295986A (ja) | トリレオウイルスの新規抗原クラス | |
| LU81687A1 (fr) | Vaccin combine contre la maladie de newcastle et la chute de ponte provoquee par des virus adeno-like | |
| RU2378014C2 (ru) | Ассоциированная вакцина против парагриппа-3, инфекционного ринотрахеита и коронавирусной инфекции крупного рогатого скота эмульсионная инактивированная | |
| EP2550015B1 (fr) | Vaccin vivant pour maladies aviaires | |
| RU2443429C2 (ru) | Вакцина ассоциированная против ньюкаслской болезни птиц, инфекционного бронхита кур, синдрома снижения яйценоскости-76, инфекционной бурсальной болезни и реовирусного теносиновита птиц инактивированная эмульсионная | |
| LU82018A1 (fr) | Vaccins contre des maladies provoquees par des reovirus et procede de preparation de ces vaccins | |
| NL8005577A (nl) | Werkwijze voor het bereiden van een vaccin. | |
| BE878804A (fr) | Vaccin combine contre la maladie de newcastle et le chute de ponte provoquee par des virus adeno-like | |
| EP0029047A1 (en) | Combined inactivated vaccine, ready for administration and process for the preparation of such vaccine, active against egg production drop caused by adeno like viruses and against diseases caused by reo viruses | |
| CH382917A (fr) | Procédé pour la production d'un virus-vaccin contre la maladie des chiens | |
| RU2480238C1 (ru) | Вакцина ассоциированная против ньюкаслской болезни, реовирусного теносиновита и метапневмовирусной инфекции птиц инактивированная эмульсионная | |
| JPS6244528B2 (enrdf_load_stackoverflow) | ||
| US3629396A (en) | Avian encephalomyelitis vaccine | |
| JPH05501565A (ja) | ワクチン接合体の使用方法、ワクチン調整物および製造品 | |
| JPS62201573A (ja) | 家禽用インフルエンザワクチン | |
| WO2009013551A2 (en) | Process for preparing viral vaccine | |
| USRE34013E (en) | Infectious bronchitis vaccine for poultry | |
| GB2048669A (en) | Canine distemper vaccines | |
| EP0186368A2 (en) | Biological preparations | |
| NL7906696A (nl) | Kant en klaar, gecombineerd vaccin en werkwijze voor het bereiden van dit gecombineerd vaccin tegen pseudovogelpest en door adeno achtige virussen veroorzaakte eiproduktiedalingen. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RE | Patent lapsed |
Owner name: GIST-BROCADES N.V. Effective date: 19910930 |